Class II
Terminated
Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceutical Industries, Inc.
Why: Subpotent drug
- Company
- SUN PHARMACEUTICAL INDUSTRIES INC
Princeton, NJ, United States - Reported
- Jul 5, 2023
- Recall started
- May 30, 2023
- Ended
- Dec 18, 2023
- Where sold
- USA nationwide
- Amount
- 12960 vials
- Full product description
- Amphotericin B Liposome for Injection, 50mg/vial, Rx only, Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by Sun Pharmaceutical Medicare Limited, Baska Ujeti Road, Ujeti, Halol-389350, Gujarat, India, NDC 62756-0233-01
- Lots / codes affected
- Lot # BAD0089A, Exp 01/2025; BAD0330A, Exp 07/2025
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.